Burgess B. Freeman III

“Why” was completing a residency at Ohio State beneficial to your career?”

I would say my time at OSUMC was an accelerated, intense introduction to the world of clinical pharmacy and the academic biomedical apparatus. I learned about appropriate and pragmatic application of pharmacotherapy across diverse practice areas; this has benefitted my career in the field of drug discovery and development. I also learned “soft skills,” like how to effectively interact with colleagues of a varying nature and to be part of a team (“Code Blues” come to mind). The pharmacy administration rotations exposed me to basic tenants I’ve built upon through my career, and often use in my responsibilities as a core laboratory director. Finally, the relationships I formed with preceptors and fellow residents endure to this day. I am grateful to have had my experiences at OSUMC, and to call myself an alum of the program.

Any particular career accomplishments you would like to highlight? Publications, Awards, Grant Funding, etc?

I was recently an integral part of a team responsible for moving SJCRH’s first ever novel small molecule investigational new drug toward the clinic. The antimalarial SJ733 is slated for a single ascending dose Phase I study in healthy subjects in early 2016.

I was a co-author on several recent manuscripts in Cancer Cell and Cell Reports, both of which are high-impact journals in the field of oncology research.